Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
Pfizer, which with German company BioNTech won approval for the first vaccine to counter the deadly virus, sees slightly lower 2022 revenues for the vaccine compared the just-finished year, but a big infusion of revenues from Paxlovid, the company's pill for Covid-19.
PREMIUM World
Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
